logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9359279 B1

PDFFull Text
Expired
Date of Patent:
Jun. 07, 2016

Filed:

Aug. 28, 2014

Treatment of cancer, inflammatory disease, and autoimmune disease

Applicant:

Androscience Corporation, Solana Beach, CA (US);

Inventors:

Charles C-Y Shih, San Diego, CA (US);

Toshio Kitamura, Tokyo, JP;

Qian Shi, Chapel Hill, NC (US);

Toshiyuki Kawashima, Solana Beach, CA (US);

Hui-Kang Wang, San Diego, CA (US);

Assignee:

Allianz Pharmascience Ltd., Taipei, TW;

Attorney:

Cesari and McKenna LLP

Primary Examiner:

Janet L Andres

Assistant Examiner:

Ben S Michelson

Int. Cl.
CPC ...
C07D 211/20 (2006.01); C07C 49/00 (2006.01); C07C 307/00 (2006.01); C07C 309/00 (2006.01); C07C 303/00 (2006.01); C07C 311/00 (2006.01); C07F 9/02 (2006.01); C07C 233/00 (2006.01); C07C 235/00 (2006.01); C07C 237/00 (2006.01); C07C 239/00 (2006.01); C07C 213/00 (2006.01); C07C 215/00 (2006.01); C07C 217/00 (2006.01); A61K 31/66 (2006.01); A61K 31/12 (2006.01); A61K 31/255 (2006.01); A61K 31/445 (2006.01); A61K 31/165 (2006.01); A61K 31/135 (2006.01); A61K 31/535 (2006.01); C07C 49/248 (2006.01); C07C 49/235 (2006.01); C07C 49/255 (2006.01); C07C 69/16 (2006.01); C07C 217/22 (2006.01); C07C 235/82 (2006.01); C07C 307/02 (2006.01); C07C 309/65 (2006.01); C07C 309/66 (2006.01); C07C 309/73 (2006.01); C07C 317/24 (2006.01); C07D 213/68 (2006.01); C07D 295/112 (2006.01); C07F 9/12 (2006.01); C07F 9/32 (2006.01); C07C 217/60 (2006.01); C07D 295/13 (2006.01); C07F 9/06 (2006.01); C07F 9/09 (2006.01);
U.S. Cl.
CPC ...
C07C 49/248 (2013.01); C07C 49/235 (2013.01); C07C 49/255 (2013.01); C07C 69/16 (2013.01); C07C 217/22 (2013.01); C07C 217/60 (2013.01); C07C 235/82 (2013.01); C07C 307/02 (2013.01); C07C 309/65 (2013.01); C07C 309/66 (2013.01); C07C 309/73 (2013.01); C07C 317/24 (2013.01); C07D 213/68 (2013.01); C07D 295/112 (2013.01); C07D 295/13 (2013.01); C07F 9/06 (2013.01); C07F 9/09 (2013.01); C07F 9/12 (2013.01); C07F 9/32 (2013.01); C07F 9/3282 (2013.01); C07C 2101/14 (2013.01); C07C 2101/16 (2013.01);
Abstract

A method of treating cancer, inflammatory disease, and autoimmune disease by administering to a subject in need thereof an effective amount of one or more 1,5-dipenylpenta-1,4-dien-3-one compounds. The compounds feature either or both of the phenyl rings being substituted with hydroxyl, diethyl(2-alkoxyethyl)amine, 1-(2-alkoxyethyl)piperidine, sulfonate, phosphinate, or phosphate.

Find Patent Forward Citations

Shih, Charles C-Y. (2016). Treatment of cancer, inflammatory disease, and autoimmune disease (U.S. Patent No. 9359279). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9359279

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…